MDM2 SNP309 promoter polymorphism and p53 mutations in urinary bladder carcinoma stage T1
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2490
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
MDM2 SNP309 promoter polymorphism and p53 mutations in urinary bladder carcinoma stage T1 ; volume:13 ; number:1 ; day:28 ; month:1 ; year:2013 ; pages:1-8 ; date:12.2013
BMC urology ; 13, Heft 1 (28.1.2013), 1-8, 12.2013
- Creator
-
Olsson, Hans
- Contributor
-
Hultman, Per
Rosell, Johan
Söderkvist, Peter
Jahnson, Staffan
SpringerLink (Online service)
- DOI
-
10.1186/1471-2490-13-5
- URN
-
urn:nbn:de:1111-2016071625008
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:47 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Olsson, Hans
- Hultman, Per
- Rosell, Johan
- Söderkvist, Peter
- Jahnson, Staffan
- SpringerLink (Online service)
Other Objects (12)
SNP55, a new functional polymorphism of MDM2-P2 promoter, contributes to allele-specific expression of MDM2 in endometrial cancers
Evolution of the p53-MDM2 pathway
MDM2 promoter polymorphism del1518 (rs3730485) and its impact on endometrial and ovarian cancer risk
Small-Molecule Inhibitors of p53-MDM2 interactions
Serumantikörper gegen die Proteine p53, mdm2 und p21-waf1 und Nachweis der Proteine p53 und mdm2 in menschlichen Tumorgeweben
CDK4 inhibition diminishes p53 activation by MDM2 antagonists
Targeting p53–MDM2 interaction by small-molecule inhibitors: learning from MDM2 inhibitors in clinical trials
NAT 10 regulates p53 activation through acetylating p53 at K120 and ubiquitinating Mdm2
Engineering a synthetic p53-Mdm2 network in budding yeast
Explaining oscillations and variability in the p53-Mdm2 system
Mad1 destabilizes p53 by preventing PML from sequestering MDM2
Stress-specific response of the p53-Mdm2 feedback loop
SNP55, a new functional polymorphism of MDM2-P2 promoter, contributes to allele-specific expression of MDM2 in endometrial cancers
Evolution of the p53-MDM2 pathway
MDM2 promoter polymorphism del1518 (rs3730485) and its impact on endometrial and ovarian cancer risk
Small-Molecule Inhibitors of p53-MDM2 interactions
Serumantikörper gegen die Proteine p53, mdm2 und p21-waf1 und Nachweis der Proteine p53 und mdm2 in menschlichen Tumorgeweben
CDK4 inhibition diminishes p53 activation by MDM2 antagonists
Targeting p53–MDM2 interaction by small-molecule inhibitors: learning from MDM2 inhibitors in clinical trials
NAT 10 regulates p53 activation through acetylating p53 at K120 and ubiquitinating Mdm2
Engineering a synthetic p53-Mdm2 network in budding yeast
Explaining oscillations and variability in the p53-Mdm2 system
Mad1 destabilizes p53 by preventing PML from sequestering MDM2
Stress-specific response of the p53-Mdm2 feedback loop
SNP55, a new functional polymorphism of MDM2-P2 promoter, contributes to allele-specific expression of MDM2 in endometrial cancers
Evolution of the p53-MDM2 pathway
MDM2 promoter polymorphism del1518 (rs3730485) and its impact on endometrial and ovarian cancer risk
Small-Molecule Inhibitors of p53-MDM2 interactions
Serumantikörper gegen die Proteine p53, mdm2 und p21-waf1 und Nachweis der Proteine p53 und mdm2 in menschlichen Tumorgeweben
CDK4 inhibition diminishes p53 activation by MDM2 antagonists
Targeting p53–MDM2 interaction by small-molecule inhibitors: learning from MDM2 inhibitors in clinical trials
NAT 10 regulates p53 activation through acetylating p53 at K120 and ubiquitinating Mdm2
Engineering a synthetic p53-Mdm2 network in budding yeast
Explaining oscillations and variability in the p53-Mdm2 system
Mad1 destabilizes p53 by preventing PML from sequestering MDM2